RECRUITING

Treatment Results for Patients with Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study

Talk to us

Conditions

Central Centrifugal Cicatricial Alopecia (CCCA)alopeciaHair lossFemale hair lossMinoxidilTopical Steroid

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The objective of this study is to examine photos of CCCA patients taken before and after treatment to compare treatment outcomes between different treatment groups

Official Title

Treatment Results for Patients with Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study

Quick Facts

Study Start:2018-04-30
Study Completion:2025-03
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04207931

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 60 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * African-American women, ages 18-60 years old
  2. * with a clinical diagnosis and biopsy-proven CCCA, with Central Scalp Alopecia Scale severity 1 through 4 will be included in this study
  3. * These subjects will be seen and treated in Wake Forest Baptist Health Dermatology Outpatient Clinic
  1. * Patients with other forms of hair loss in addition to CCCA will be excluded
  2. * Other patients to be excluded are those with other forms of inflammatory scalp disease (with the exception of mild seborrheic dermatitis)
  3. * patients who have had topical treatment for CCCA within the past 4 months (including topical steroids, topical minoxidil, or any other topical hair regrowth medication)
  4. * patients who have been on a long-term oral antibiotics for hair loss within the past year
  5. * patients who have undergone more than two rounds of intralesional steroid injections to the scalp in the past one year.

Contacts and Locations

Study Contact

Amy J McMichael, MD
CONTACT
336.716.3926
amcmichael@wakehealth.edu
Judy Holbrook, CRC
CONTACT
336.716.8991
jholbroo@wakehealth.edu

Principal Investigator

Amy J McMichael, MD
PRINCIPAL_INVESTIGATOR
Wake Forest Baptist Health Department of Dermatology

Study Locations (Sites)

Wake Forest Baptist Health Department of Dermatology
Winston-Salem, North Carolina, 27157
United States

Collaborators and Investigators

Sponsor: Wake Forest University Health Sciences

  • Amy J McMichael, MD, PRINCIPAL_INVESTIGATOR, Wake Forest Baptist Health Department of Dermatology

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2018-04-30
Study Completion Date2025-03

Study Record Updates

Study Start Date2018-04-30
Study Completion Date2025-03

Terms related to this study

Keywords Provided by Researchers

  • alopecia
  • Hair loss
  • Female hair loss
  • Minoxidil
  • Topical Steroid

Additional Relevant MeSH Terms

  • Central Centrifugal Cicatricial Alopecia (CCCA)